AIRA was founded by a team of curious minds working at the intersection of clinical development, technology, econometrics, and mathematics - united by a shared experience: the understanding that it is critical for treatments to reach patients at the right time.
Our CEO, Levi, experienced this reality firsthand during his years as a competitive athlete, when effective treatment options were not available when he needed them most. That experience ultimately brought him to Boston, where he studied at Harvard and worked at Mass General Brigham. While collaborating closely with some of the world's leading researchers and clinicians, a broader challenge became clear: the journey from scientific discovery to approved therapy is long, complex, and too often slowed not by science itself, but by fragmented processes and increasingly complex decision-making.
Early on, one insight stood out. Clinical development is fundamentally an exercise in alignment - bringing together science, safety, regulatory expectations, operational execution, and human judgment across many stakeholders. Yet the systems supporting this process were prone to misalignment, repeated work, and costly delays. The solution was not simply automating inefficient workflows, but rethinking how clinical development itself should operate - making it safer, faster, and more coherent from the ground up.
While many AI solutions focused on faster text generation or isolated automation, the AIRA team took a different path. We brought together clinicians, mathematicians, engineers, and world-class industry advisors to build something deeper: a unified platform with an intelligence layer designed to support how clinical decisions are actually made and how AI can support teams to make better, defensible decisions. Our ambition was not incremental efficiency but a structural shift toward a new, regulatory-grade approach to developing therapies with AI.
Today, AIRA is built to address the underlying complexity of clinical development and help establish a new standard for how studies are designed - ensuring that the right treatments reach patients faster and more safely. Because every failed study delays a cure.
AIRA now supports a growing community of leading clinical development teams and experts around the world as they design the next generation of therapies.
